Health Care Stocks Rally as Defensive Rotation Deepens

UnitedHealth Group and Humana continue to outperform, with UnitedHealth shares climbing 13% over the past four weeks. This sustained momentum reflects a tactical move by institutional investors prioritizing the steady cash flows inherent to large-scale insurance providers.

Technological integration remains a primary growth driver for the broader industry. AstraZeneca announced a strategic collaboration with Oracle to leverage artificial intelligence for clinical research refinement, marking another milestone in the sector's push to optimize drug development timelines through data processing. Meanwhile, clinical results provided a boost for smaller players; Rapport Therapeutics saw its stock climb following positive mid-stage trial data for a bipolar disorder treatment candidate, signaling appetite for risk remains in specialized therapeutic segments.